ArticleClinical cardiology2026
The Association between Hypoperfused Myocardium and Systolic Function in Patients With AMI Undergoing Complete Revascularization.
Article in Clinical cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Association between Hypoperfused Myocardium and Systolic Function in Patients With AMI Undergoing Complete Revascularization.Clinical cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundTimely restoring coronary blood flow reduces mortality in acute myocardial infarction (AMI), while epicardial flow restoration is non-parallel to myocardial reperfusion. This prospective study examined temporal changes in myocardial perfusion and their association with left ventricular (LV) systolic function after complete revascularization.
methodsAMI patients treated with complete revascularization underwent hybrid positron emission tomography/magnetic resonance imaging (PET/MR) at 2 months and 1 year after the index procedure. Hypoperfused myocardium was defined as reduced perfusion with preserved metabolism.
resultsFifty-five patients (60.42 ± 11.47 years, 80.0% male) were enrolled, and hypoperfused myocardium (median: 12% of LV) was detected in 25 (45.5%) patients 2 months post-AMI. Patients with and without hypoperfused myocardium were classified as Group A and Group B, respectively. Higher high-sensitivity C-reactive protein (hs-CRP) and lower T2 values were observed in Group A and independently predicted baseline hypoperfused myocardium. At 1-year PET/MR follow-up, six (31.6%) patients in Group A showed perfusion recovery; these patients were more frequently female (p = 0.025), less frequently diabetic (p = 0.044) or overweight (p = 0.035), and had better baseline global longitudinal strain (GLS) (p = 0.005). Significant LV ejection fraction improvement was observed in Group A (56.39% ± 9.76% vs. 54.58% ± 10.39%, p = 0.016) but not in Group B (51.63% ± 13.09% vs. 50.79% ± 16.95%, p = 0.615).
conclusionsEven after complete revascularization, myocardial hypoperfusion may persistently exist and evolve over time in AMI patients. The reversal of myocardial hypoperfusion is possibly associated with improved LV systolic function.
trial registrationThe study was retrospectively registered on 2022-11-24 under the name Evaluation of short-and long-term cardiac structure and function in patients with acute coronary syndrome and made publicly available in the China Medical Research Registration Information System (https://www.medicalresearch.org.cn/), with the registration number MR.-11-23-000090.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.